Found: 16
Select item for more details and to access through your institution.
Chronic myeloid leukaemia patients at diagnosis and resistant to tyrosine kinase inhibitor therapy display exhausted T‐cell phenotype.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 6, p. 1011, doi. 10.1111/bjh.18302
- By:
- Publication type:
- Article
High-flow nasal cannula oxygen in patients with haematological malignancy: a retrospective observational study.
- Published in:
- Annals of Hematology, 2022, v. 101, n. 6, p. 1191, doi. 10.1007/s00277-022-04824-9
- By:
- Publication type:
- Article
Anti‐type M phospholipase A2 receptor antibody‐positive membranous nephropathy as a part of multi‐system autoimmune syndrome post‐allogeneic stem cell transplantation.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
Features and Risk Factors of Peripheral Neuropathy During Treatment with Bortezomib for Advanced Multiple Myeloma.
- Published in:
- Clinical Lymphoma & Myeloma, 2008, v. 8, n. 3, p. 146
- By:
- Publication type:
- Article
Vaccination Strategies in Lymphomas and Leukaemias: Recent Progress.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Alemtuzumab vs anti‐thymocyte globulin in patients transplanted from an unrelated donor after a reduced intensity conditioning.
- Published in:
- European Journal of Haematology, 2018, v. 101, n. 4, p. 466, doi. 10.1111/ejh.13085
- By:
- Publication type:
- Article
CML-129: OPTIC Primary Analysis: A Dose-Optimization Study of 3 Starting Doses of Ponatinib (PON).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S328, doi. 10.1016/S2152-2650(21)01769-9
- By:
- Publication type:
- Article
Poster: CML-129: OPTIC Primary Analysis: A Dose-Optimization Study of 3 Starting Doses of Ponatinib (PON).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S223, doi. 10.1016/S2152-2650(21)01408-7
- By:
- Publication type:
- Article
Oral Abstract: CML-129: OPTIC Primary Analysis: A Dose-Optimization Study of 3 Starting Doses of Ponatinib (PON).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S202, doi. 10.1016/S2152-2650(21)01274-X
- By:
- Publication type:
- Article
Clinical Intervention Using NGS-Based Kinase Domain Mutation Testing in CML Patients.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S293, doi. 10.1016/j.clml.2019.07.241
- By:
- Publication type:
- Article
Epstein-Barr Virus and Monoclonal Gammopathy of Clinical Significance in Autologous Stem Cell Transplantation for Multiple Sclerosis.
- Published in:
- Clinical Infectious Diseases, 2019, v. 69, n. 10, p. 1757, doi. 10.1093/cid/ciz047
- By:
- Publication type:
- Article
Differential Interaction of Peripheral Blood Lymphocyte Counts (ALC) With Different in vivo Depletion Strategies in Predicting Outcomes of Allogeneic Transplant: An International 2 Center Experience.
- Published in:
- Frontiers in Oncology, 2019, p. 1, doi. 10.3389/fonc.2019.00623
- By:
- Publication type:
- Article
Sustained response after reduced-intensity conditioning allogeneic stem cell transplantation for patients with relapsed peripheral T-cell non-Hodgkin lymphoma.
- Published in:
- 2008
- By:
- Publication type:
- Letter
Pleural effusions in patients with chronic myeloid leukaemia treated with dasatinib may have an immune-mediated pathogenesis.
- Published in:
- 2008
- By:
- Publication type:
- Letter
Reduced-intensity conditioning allogeneic stem cell transplantation for patients with chemoresistant or relapsed follicular lymphoma.
- Published in:
- 2006
- By:
- Publication type:
- Letter
A Novel PCM1-PDGFRB Fusion in a Patient with a Chronic Myeloproliferative Neoplasm and an ins(8;5).
- Published in:
- 2017
- By:
- Publication type:
- Case Study